Found 0 matching trials
Study of Pomalidomide, Oral Dexamethasone and Ixazomib in Patients With Relapsed MM Who Have Received Lenalidomide PHASE4 The purpose of this study is to evaluate the efficacy and safety of ixazomi...
Show More Learn More & Join Trial
Study of Bendamustine and IXAZOMIB (MLN9708) Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma PHASE1 This Phase I/II study is designed to first identify doses of MLN9708 and be...
Show More Location
Froedtert Hospital and the Medical College of Wisconsin
Learn More & Join Trial
A Study of Ixazomib+Daratumumab+Dexamethasone (IDd) in Relapsed and/or Refractory Multiple Myeloma (RRMM) PHASE2 The purpose of this study is to evaluate the percentage of participants wit...
Show More Location
Pacific Cancer Medical Center
Learn More & Join Trial
Ixazomib In Combination With Cyclophosphamide And Dexamethasone for Newly Diagnosed AL Amyloidosis PHASE1 Light chain (AL) amyloidosis is a bone marrow disorder that affects a wide ...
Show More Location
Icahn School of Medicine at Mount Sinai
Learn More & Join Trial
Ixazomib Citrate in Treating Patients With Chronic Graft-versus-Host Disease PHASE2 This phase II trial studies how well ixazomib citrate works in treating pat...
Show More Location
Moffitt Cancer Center
Learn More & Join Trial
Ixazomib, Cyclophosphamide and Dexamethasone for Multiple Myeloma PHASE2 The goal of this proposal is to develop a more effective and better tolerat...
Show More Location
Memorial Hospital of Rhode Island
Learn More & Join Trial
Study of Oral Ixazomib Maintenance Therapy After Initial Therapy in Participants With Newly Diagnosed Multiple Myeloma Not Treated With Stem Cell Transplantation (SCT) PHASE3 The purpose of this study is to determine the long-term safety and tolerabi...
Show More Location
Beijing Chaoyang Hospital Capital Medical University
Learn More & Join Trial
Study of Ixazomib With Pegylated IFN-alpha 2b (pIFN) in Metastatic Renal Cell Carcinoma (mRCC) PHASE1 This is a Phase I/II trial of the combination pegylated IFN-alpha 2b with i...
Show More Location
Fox Chase Cancer Center
Learn More & Join Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma PHASE1 This randomized phase I/II trial studies the side effects and best dose of ...
Show More Location
Anchorage Associates in Radiation Medicine
Learn More & Join Trial
Study of Ixazomib to Prevent Recurrent or Late Acute and Chronic Graft-versus-Host Disease 1-year After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Malignancies PHASE2 This is a single arm open label phase 2 study evaluating the potential effe...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial